About Biosynexus
biosynexus incorporated is a biopharmaceutical company that is developing a monoclonal antibody, pagibaximab, to prevent staphylococcal sepsis in very low birth weight (vlbw) infants... Read more
biosynexus incorporated is a biopharmaceutical company that is developing a monoclonal antibody, pagibaximab, to prevent staphylococcal sepsis in very low birth weight (vlbw) infants... Read more
Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with Tomba.